Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121732-18-1

Post Buying Request

121732-18-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121732-18-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 121732-18-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,7,3 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 121732-18:
(8*1)+(7*2)+(6*1)+(5*7)+(4*3)+(3*2)+(2*1)+(1*8)=91
91 % 10 = 1
So 121732-18-1 is a valid CAS Registry Number.

121732-18-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-bis(bromomethyl)-3-methylimidazo<4,5-g>quinazoline-4,8,9(3H,7H)-trione

1.2 Other means of identification

Product number -
Other names 2,6-Bis-bromomethyl-3-methyl-3H,7H-imidazo[4,5-g]quinazoline-4,8,9-trione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121732-18-1 SDS

121732-18-1Downstream Products

121732-18-1Relevant articles and documents

Studies of Extended Quinone Methides. Synthesis and Physical Studies of Purine-like Monofunctional and Bifunctional Imidazoquinazoline Reductive Alkylating Agents

Lemus, Robert H.,Lee, Chang-Hee,Skibo, Edward B.

, p. 3611 - 3618 (2007/10/02)

Described herein are the synthesis, quinone methide reactivity, and electrochemistry of purine-like imidazoquinazoline reductive alkylating agents possessing a leaving group at the 6α-position.Also described is the synthesis of a dual-alkylating analogue possessing a leaving group at both the 2α- and 6α-positions.The reductive alkylating agent design involves leaving group placement on the 4,9-dione (quinone) derivative of the title ring system so as to permit formation of an alkylating quinone methide species upon reduction to the hydroquinone and elimination of the leaving group.The purine-like structure of these reductive alkylating agents may permit selective inactivation of purine-utilizing enzymes in low reduction potential tumor cells.Comparisons of our finding with those obtained for an analogous reductive alkylation system revealed the following: (i) lowering the quinone reduction potential greatly enhances the rate of leaving group elimination (e.g., a 2300-fold increase in the rate of chloride elimination accompanies a 200-mV potential decrease), and (ii) lower potentials favor electrophile trapping (ketonization) over nucleophile trapping of the quinone methide intermediate.The results of our studies indicate electrochemical studies are valuable in predicting the reactivity pattern of a reductive alkylating agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121732-18-1